PIPELINE THERAPEUTICS INC has a total of 17 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are NANJING BAIJINGYU PHARMACEUTICAL CO LTD, SPRUCE BIOSCIENCES INC and ALGERNON PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | United States | 2 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lorrain Daniel Scott | 7 |
#2 | Stebbins Karin Joy | 7 |
#3 | Poon Michael Ming-Yuan | 6 |
#4 | Chen Austin | 5 |
#5 | Xiong Yifeng | 5 |
#6 | Schrader Thomas | 5 |
#7 | Roppe Jeffrey | 4 |
#8 | Baccei Jill | 4 |
#9 | Lee Catherine Yuling | 2 |
#10 | Seiders Thomas Jon | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021071843A1 | Muscarinic acetylcholine m1 receptor antagonists | |
AU2019336671A1 | Muscarinic acetylcholine M1 receptor antagonists | |
WO2019241131A1 | Muscarinic acetylcholine m1 receptor antagonists | |
KR20190098998A | How to treat cochlear synaptic disease | |
AU2016344138A1 | Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders |